Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Depression 3Polycystic Ovary Syndrome 2Depressive Disorder, Major 2Neoplasms 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Asthma 1

Interventions

Metformin 41Clomiphene 17Letrozole 6Menotropins 5Folic Acid 5drospirenone and ethinyl estradiol combination 4Liraglutide 4Chorionic Gonadotropin 4cetrorelix 3Triptorelin Pamoate 3Progesterone 3Pioglitazone 3Leuprolide 3Inositol 3Exenatide 3Ethinyl Estradiol 3Estradiol 3Vitamins 2Sperm Injections, Intracytoplasmic 2Sitagliptin Phosphate 2Simvastatin 2Gonadotropins 2Glycoprotein Hormones, alpha Subunit 2Exercise 2Escitalopram 2Cyproterone acetate, ethinyl estradiol drug combination 2Contraceptives, Oral 2Cholecalciferol 2Carnitine 2Canagliflozin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Polycystic Ovary Syndrome × Escitalopram × Clear all
NCT05840692 2023-05-03

The Effect of Escitalopram in PCOS

Odense University Hospital

Phase 4 Completed
40 enrolled

Polycystic Ovary Syndrome

NCT01961180 2016-05-09

The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOS

Odense University Hospital

Phase 4 Completed
42 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡